ALEXANDRA JURENKA: Open Payments
NPI 1376099242 · SAGINAW, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,536 in 75 payments from 20 companies in 2025. Trend: 2023 $543 · 2024 $1,693 · 2025 $1,536
Food & beverage: $1,536
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $297 |
| Dexcom, Inc. | 6 | $173 |
| Insulet Corporation | 6 | $120 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $113 |
| Lilly USA, LLC | 8 | $113 |
| ABBVIE INC. | 5 | $91 |
| Ascendis Pharma Endocrinology Inc | 4 | $89 |
| Corcept Therapeutics | 4 | $86 |
| Tandem Diabetes Care, Inc. | 4 | $81 |
| Abbott Laboratories | 3 | $64 |
Products named: Wegovy, Dexcom G6 Transmitter, Omnipod, JARDIANCE, MOUNJARO, Yorvipath, Korlym, t:slim X2 Insulin Pump with Control-IQ.
Industry payments across MI — which companies pay providers there.
